Jeffrey S. Cohen

Analyst-Equity chez Ladenburg Thalmann & Co., Inc. (Broker)

Profil

Mr. Jeffrey S.
Cohen is Managing Director of Equity Research at Ladenburg Thalmann & Co., Inc. He is responsible for equity research coverage of medical technology and healthcare services.
He has over 19 years of experience directly involved in the worldwide financial markets, of which he has spent the past 11 years directly involved with healthcare research and sales.
Prior to joining Ladenburg Thalmann, Mr. Cohen was a Senior Healthcare Research Analyst at C.K.
Cooper & Company focusing upon the biotechnology, medical technology, and healthcare services segments.
Mr. Cohen also served as a healthcare research analyst at Jesup & Lamont Inc., where he focused upon medical technology with sector specialization within Cardiology, Vascular, Orthopedics and Diabetes.
Prior to equity research & sales, he spent seven years trading and managing fixed-income and equity derivative products at Cantor Fitzgerald, Sanwa Securities and the American Stock Exchange.
He holds a B.S.E.
in Systems Engineering from the University of Pennsylvania and an M.B.A. from the University of Miami.

Postes actifs de Jeffrey S. Cohen

Sociétés	Poste	Début
Ladenburg Thalmann & Co., Inc. (Broker)	Analyst-Equity	01/08/2011

Anciens postes connus de Jeffrey S. Cohen

Sociétés	Poste	Fin
Jesup & Lamont Securities Corp.	Analyst-Equity	30/12/2007
Cantor Fitzgerald Securities	Corporate Officer/Principal	01/01/1998
C.K. Cooper & Co.	Analyst-Equity	-
Biologic Investment Research LLC	Directeur de la Recherche - Actions	21/09/2011